Vaginal bacteria on newborn skin produce a lipid that reaches the brain and affects neural signaling (Apr 2026) Vaginal microbiota transfer ameliorates cesarean-associated neurodevelopmental deficits in mice via N-bc2S1P synthesis on neonatal skin Origins

[Michael Harrop]

https://www.science.org/content/article/vaginal-bacteria-turn-newborn-skin-beneficial-bioreactor
https://www.sciencedirect.com/science/article/abs/pii/S1931312826001319

I tagged it as "origins" because it deals with vaginal seeding.

I've thought that vaginal seeding (smearing vaginal microbes on the infant's skin) doesn't make sense because I don't see how microbes smeared on the skin could colonize the gut, but this study indicates that skin microbes can create compounds that reach the brain.

Highlights​

• VMT restores skin N-bc2S1P linked to early neurodevelopment in cesarean-born neonates
• N-bc2S1P engages β-arrestin1-biased S1PR2 signaling in forebrain excitatory neurons
• β-arrestin1-biased S1PR2 signaling recruits AP-1/CBP to increase Notch H3K27ac
• Engineered S. epidermidis sustains N-bc2S1P and extends rescue of CS-associated deficits

Click to shrink...

Summary​

Cesarean section (CS) bypasses neonatal exposure to maternal vaginal microbiota, leaving the metabolic contribution of skin microbiota to neurodevelopment unclear. In CS neonates receiving vaginal microbiota transfer, skin multi-omics at 24 h identified restoration of β-carboline-sphingosine-1-phosphate (N-bc2S1P), whose levels correlated with ASQ-3 scores at 3 and 6 months. In mice, N-bc2S1P assembled on neonatal skin by Lactobacillus crispatus and Bacteroides fragilis reaches the brain and selectively triggers β-arrestin1-biased S1PR2 signaling in forebrain excitatory neurons. This pathway promotes AP-1/CBP recruitment, increases H3K27 acetylation at Notch loci, and transiently ameliorates CS-associated early-life neurodevelopmental impairments. Because N-bc2S1P is rapidly cleared, we engineered the skin commensal Staphylococcus epidermidis to co-synthesize β-carboline and S1P, sustaining cutaneous N-bc2S1P production, prolonging brain exposure, and improving neurodevelopmental outcomes. These findings identify a microbe-derived, arrestin-biased S1PR2 agonist and show that engineered skin commensals extend transient maternal microbial signals into more durable neurodevelopmental benefit in mice.

Click to shrink...

Maria Gloria Dominguez-Bello, a biologist who pioneered vaginal seeding and has also described neonatal skin colonization by vaginal microbes, praised the study as “compelling evidence for a previously underappreciated skin-microbe-brain axis,” although she cautions the skin is probably just one route by which maternal microbes affect newborns’ development. Hourigan agrees that “many pathways are probably involved. … But if you can get small improvements even in a few pathways, that could be beneficial.”

Although evidence favoring vaginal seeding is accumulating, it’s still not standard practice, and the American College of Obstetricians and Gynecologists does not recommend the procedure outside clinical trials, partly because of the risk of transmitting infections. Hourigan says that Zhang and colleagues’ study points to the possibility of using bacterial metabolites—or medicines developed from them—in lieu of vaginal flora. “But then you’re potentially taking a simple, inexpensive treatment and making it less accessible,” she says.

Click to shrink...